Cost-effectiveness Analysis of Reference Infliximab (Remicade) Compared to its Biosimilar (Remsima) in Iraqi Patients with Rheumatoid Arthritis (Conference Paper )#
The study objective was to conduct Pharmacoeconomics study (cost-effective analysis) between infliximab reference (Remicade) and its biosimilar (Remsima) in patients with rheumatoid arthritis (RA) in Iraqi hospitals. This is a retrospective multicenter pharmacoeconomic analysis conducted at two...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
College of Pharmacy University of Baghdad
2023-02-01
|
| Серии: | Iraqi Journal of Pharmaceutical Sciences |
| Предметы: | |
| Online-ссылка: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2033 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|